LG Energy Solution to Combat Infringement By Launching Licensing Business for Battery Patents 
Crypto.com's Launch in South Korea Stalled by AML Regulatory Concerns, Postponement Announced 
Why is the London Stock Exchange losing out to the US 
Amazon to Introduce Air Delivery Service in Arizona via Drone 
Supreme Court appears open to Starbucks’ claims in labor-organizing case 
PUMA x Ottolinger Unveil Futuristic Collection Inspired by Motorsport and Sci-Fi 
7-Eleven Reveals Global Growth Plan to Boost Its F&B Programs 
The language of insolvency: why getting it wrong can harm struggling firms 
Tesla Nears FSD Licensing Deal with Major Automaker, Hits 1.3 Billion Milestone 
Coca-Cola, Microsoft Forge $1.1B Alliance for Cloud and AI Innovation 
Tesla Wipes Out New Content Marketing Unit, Fired All Team Members 
Apple Adds Eight Chinese Companies to Its Supply Chain After Axing Four 
US Supreme Court Signals Support for Starbucks in Landmark Labor Law Case 
Tesla Reveals Plans to Release New EVs Earlier Than Scheduled, to Introduce Cheaper Models 
Huawei Introduces Smart Driving Software Brand Qiankun 
Volvo Cars Projects Robust Demand Despite Financial Hiccups in Q1 
ROCKVILLE, Md., March 28, 2017 -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 16th Annual Needham Healthcare Conference on Tuesday, April 4th at 12:10 PM ET.
Investors interested in arranging a meeting with the Company's management during this conference should contact the conference coordinator.
The presentation will be webcast live and may be accessed from the Event Calendar page of Sucampo's website at http://www.sucampo.com/investors/events-presentations/. A replay of the webcast will also be available on the Company's website for several days after the live event. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a pipeline of product candidates in clinical development. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan and Switzerland. For more information, please visit www.sucampo.com.
The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG.
Follow us on Twitter (@Sucampo_Pharma). Follow us on LinkedIn (Sucampo Pharmaceuticals).
Contact: Sucampo Pharmaceuticals, Inc. Silvia Taylor Senior Vice President, Investor Relations and Corporate Affairs 1-240-223-3718 [email protected]
